Cat.#: ACPP-1790
| Despition | MANF Rat Recombinant |
| SIZE | 5 µg |
| Purity | > 98.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1624 | Human EFNA1 Protein (AC1624) | 5 µg | inquiry |
| ACPP-1825 | Human ANKRA2 Protein (AC1825) | 2 µg | inquiry |
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
| ACPP-1233 | Galectin 3 Blocking Peptide (AC1233) | 250 µg | inquiry |
| ACPP-1733 | Human CRYGC Protein (AC1733) | 5 µg | inquiry |
| ACPP-1843 | Human PON1 Protein (AC1843) | 2 µg | inquiry |
| ACPP-1665 | Human CDK5 Protein (AC1665) | 5 µg | inquiry |
| ACPP-1677 | Mouse S100A8 Protein (AC1677) | 5 µg | inquiry |
| ACPP-1651 | Human AIDA Protein (AC1651) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.